Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$83.14 - $145.99 $6.65 Million - $11.7 Million
-80,000 Reduced 46.38%
92,498 $13.5 Million
Q1 2022

May 04, 2022

SELL
$110.08 - $142.92 $4.4 Million - $5.72 Million
-40,000 Reduced 18.82%
172,498 $20.5 Million
Q4 2021

Feb 02, 2022

SELL
$99.73 - $148.48 $1.99 Million - $2.97 Million
-20,000 Reduced 8.6%
212,498 $29.3 Million
Q3 2021

Nov 01, 2021

SELL
$98.85 - $138.91 $1.48 Million - $2.08 Million
-15,000 Reduced 6.06%
232,498 $32.3 Million
Q1 2021

May 04, 2021

BUY
$64.07 - $91.75 $3.84 Million - $5.51 Million
60,000 Added 32.0%
247,498 $16.9 Million
Q4 2020

Feb 05, 2021

SELL
$65.07 - $98.24 $4.18 Million - $6.31 Million
-64,253 Reduced 25.52%
187,498 $16.1 Million
Q3 2020

Nov 02, 2020

BUY
$59.04 - $77.95 $2.95 Million - $3.9 Million
50,000 Added 24.78%
251,751 $16.4 Million
Q2 2020

Aug 05, 2020

SELL
$29.01 - $74.23 $3.19 Million - $8.17 Million
-110,000 Reduced 35.28%
201,751 $14.8 Million
Q2 2019

Aug 02, 2019

SELL
$39.79 - $67.01 $2.79 Million - $4.69 Million
-70,000 Reduced 18.34%
311,751 $13.7 Million
Q1 2019

May 03, 2019

BUY
$34.52 - $53.29 $2.87 Million - $4.42 Million
83,001 Added 27.78%
381,751 $19.6 Million
Q4 2018

Feb 12, 2019

BUY
$29.75 - $42.9 $8.89 Million - $12.8 Million
298,750 New
298,750 $11 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.18B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track C World Wide Group Holding A Portfolio

Follow C World Wide Group Holding A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

News

Stay updated on C World Wide Group Holding A with notifications on news.